Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by jewel9mon Dec 16, 2016 10:14am

115 Views

Post# 25609682

RE:Get a deal done....1067/SGLT2 - any deal....pick a deal!

Alot of talk no action. Good post Red, This is what s been on my mind lately also. Far to much very positive talk and anticipation attitude with no results at all, for well over a year. In my opinion they have lead on investors with there language. The need to show results NOW!!!

Now were have "expect to receive at least one term sheet by year end 2016".
Really need to not say this unless you are sure it will happen.

Need a shake up in management.

Bullboard Posts

Bombardier delivers Global 6500 aircraft to U.S. Army